4//SEC Filing
IDEXX LABORATORIES INC /DE 4
Accession 0000899243-16-013153
$IDXXCIK 0000874716operating
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 7:23 PM ET
Size
9.3 KB
Accession
0000899243-16-013153
Insider Transaction Report
Form 4
CRAIG THOMAS
Director
Transactions
- Sale
Common Stock
2016-02-09$69.52/sh−2,054$142,803→ 22,298 total - Exercise/Conversion
Common Stock
2016-02-09$17.18/sh+2,054$35,298→ 24,352 total - Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2016-02-09−2,054→ 0 totalExercise: $17.18Exp: 2016-02-13→ Common Stock (2,054 underlying)
Footnotes (3)
- [F1]The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $69.2738 to $69.8301 inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- [F2]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,527 shares on February 14, 2010, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- [F3]Not applicable.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000874716
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 7:23 PM ET
- Size
- 9.3 KB